Pulmonary Hypertension (PH) Suspended Phase 2 Trials for Ambrisentan (DB06403)

Also known as: Pulmonary; Hypertension / Hypertension Pulmonary / Hypertension, Pulmonary / Pulmonary hypertensions / Pulmonary Hypertension / Other secondary pulmonary hypertension / Pulmonary hypertension NOS

IndicationStatusPhase
DBCOND0051788 (Pulmonary Hypertension (PH))Suspended2
clinicaltrials.gov IdentifierTitlePurposeDrugs